Publication:
The role of the injection Botulinum Toxin A in cases of Essential Blepharospasm Syndrome, Hemifacial Spasm and Meige’s Syndrome

creativeworkseries.issn1812-2027
dc.contributor.authorBastola, P
dc.contributor.authorChaudhary, M
dc.contributor.authorAgrawal, JP
dc.contributor.authorShah, DN
dc.date.accessioned2025-08-13T05:40:57Z
dc.date.available2025-08-13T05:40:57Z
dc.date.issued2010
dc.description1Gandaki Medical College, Charak Hospital, Kaski, Pokhara, Nepal 2,4BP Koirala Lions Centre for Ophthalmic Studies, 3Department of Medicine, Tribhuvan University Teaching Hospital, Kathmandu, Nepal
dc.description.abstractABSTRACT Background Benign Essential Blepharospasm Symdrome is a neuropathologic disorder. The cause of blepharospasm is multifactorial. It is unlikely that a single defect in this elusive control centre is the primary cause of this disease. Objectives To evaluate the role of botulinum toxin A in treating cases of Essential Blepharospasm Symdrome, Hemifacial Spasm and Meige’s Syndrome, and to assess orbicularis oculi muscle post treatment, in the patients who attended neuro-ophthalmology clinic and the general outpatient department of BP Koirala Lions Centre for Ophthalmic studies. Methods A prospective, interventional study was carried out on all the patients of Essential Blepharospasm Symdrome, Hemifacial Spasm and Meige’s syndrome who underwent treatment with botulinum toxin A in BP Koirala Lions Centre for Ophthalmic studies during a study period of one and half years. Pre- treatment grading of the spasm was done with Jankovic spasm grading and post treatment response was seen with assessment of orbicularis oculi muscle and improvement in functional impairment scale. Relevant findings were noted. Results A total of 40 cases were enrolled in the study. The mean Jankovic spasm grading in cases of essential blepharospasm, hemifacial spasm and Meige’s syndrome was 3.61 (+ Standard deviation 0.50, range 3-4), 3.21 (+Standard deviation 0.63, range 2-4) and 3.67 (+- Standard deviation 0.57, range 3-4) respectively. The mean value for reappearance of significant spasms (in months) in cases of essential blepharospasm, hemifacial spasm and Meige’s syndrome was 4.3 (+ Standard deviation 1.6, range 2.0-6.5), 5.8 (+Standard deviation 1.4, range 3-8) and 4.5 (+ Std.deviation 2.8, range 2.5-6.5) respectively. Blepharoptosis was the commonest complication accounting for 66.6% of the complications. Conclusions The movement disorders like Essential Blepharospasm, Hemifacial Hpasm and Meige’s syndrome are treated by different modalities. An acceptable and effective treatment modality has been a long felt need in these cases. Our study has shown that injection of botulinum toxin A has been a safe and effective method of treating these cases in Nepal. Key Words essential blepharospasm syndrome, hemifacial spasm, jankovic spasm grading, meige’s syndrome
dc.identifier.urihttps://hdl.handle.net/20.500.14572/1503
dc.language.isoen_US
dc.publisherKathmandu University
dc.titleThe role of the injection Botulinum Toxin A in cases of Essential Blepharospasm Syndrome, Hemifacial Spasm and Meige’s Syndrome
dc.typeArticle
dspace.entity.typePublication
local.article.typeOriginal Article
oaire.citation.endPage310
oaire.citation.startPage305
relation.isJournalIssueOfPublication990bfb68-59a2-4245-92fc-a3efc287442c
relation.isJournalIssueOfPublication.latestForDiscovery990bfb68-59a2-4245-92fc-a3efc287442c
relation.isJournalOfPublicationa782b7ff-cf89-4178-ad1c-11ed89cfe1bd

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
305-310.pdf
Size:
267.47 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.86 KB
Format:
Item-specific license agreed to upon submission
Description:

Collections